Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.073 | 0.7 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.074 | 0.7 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |